IGC $0.28 -Alzheimer Phase 2b data in Q2 ..Market cap only 18 million IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target https://finance.yahoo.com/news/igc-pharma-announces-equity-analyst-170100061.html